Citations

Clear

4847 citation(s) found for "Yu, Eric".

Dysphonia Due to Vocal Cord Injury After Rigid Bronchoscopy
Youssef, Stephanie J. , Orbelo, Diana M. , Sakata, Kenneth K. , Zimmermann, Terence M., Pittelko, Rebecca L. , Nelson, Darlene R. , Midthun, David E. , Edell, Eric S. , Ekbom, Dale C. , Orbelo, Diana

Mayo Clinic

Journal of Bronchology & Interventional Pulmonology | October 1, 2019 | Volume: 26 | Issue: 4 | Pages: e52-e55

10.1097/lbr.0000000000000587 | PMID 31569103 Get It

Parotid Gland Mass as an Initial Manifestation of Oropharyngeal Carcinoma
Dowling, Eric M. , Janus, Jeffrey R. , Dowling, Eric M.

Mayo Clinic

Ear, Nose & Throat Journal | October 1, 2019 | Volume: 100 | Issue: 5 | Pages: NP246-NP247

10.1177/0145561319869609 | PMID 31569975 Get It

Estrogen‐related receptor β activation and isoform shifting by cdc2‐like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma
Tiek, Deanna , Khatib, Subreen A. , Trepicchio, Colin J., Heckler, Mary Mazzotta, Divekar, Shailaja D., Glasgow, Eric , Sarkaria, Jann N. , Riggins, Rebecca Baab

Mayo Clinic

The FASEB Journal | September 30, 2019 | Volume: 33 | Issue: 12 | Pages: 13476-13491

10.1096/fj.201901075r | PMID 31570001 Get It

Glioblastoma (GBM; grade 4 glioma) is a highly aggressive and incurable tumor. GBM has recently been characterized as highly dependent on alternative splicing, a critical driver of tumor heterogeneity and plasticity. Estrogen‐related receptor β (ERR‐β) is an orphan nuclear receptor expressed in the brain, where alternative splicing of the 3' end of the pre‐mRNA leads to the production of 3 validated ERR‐β protein products: ERR‐β short form (ERR‐βsf), ERR‐β2, and ERR‐β exon 10 deleted. Our prior studies have shown the ERR‐β2 isoform to play a role in G 2 /M cell cycle arrest and induction of apoptosis, in contrast to the function of the shorter ERR‐βsf isoform in senescence and G 1 cell cycle arrest. In this study, we sought to better define the role of the proapoptotic ERR‐β2 isoform in GBM. We show that the ERR‐β2 isoform is located not only in the nucleus but also in the cytoplasm. ERR‐β2 suppresses GBM cell migration and interacts with the actin nucleation‐promoting factor cortactin, and an ERR‐β agonist is able to remodel the actin cytoskeleton and similarly suppress GBM cell migration. We further show that inhibition of the splicing regulatory cdc2‐like kinases in combination with an ERR‐β agonist shifts isoform expression in favor of ERR‐β2 and potentiates inhibition of growth and migration in GBM cells and intracranial tumors.—Tiek, D. M., Khatib, S. A., Trepicchio, C. J., Heckler, M. M., Divekar, S. D., Sarkaria, J. N., Glasgow, E., Riggins, R. B. Estrogen‐related receptor β activation and isoform shifting by cdc2‐like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma. FASEB J. 33, 13476–13491 (2019). www.fasebj.org
In vivo assessment of high-molecular-weight polyethylene core suture tape for intra-articular ligament reconstruction
Søreide, Endre , Denbeigh, Janet M. , Thaler, Roman , Xu, Wei , Berglund, Lawrence J., Yao, Jie , Martinez, Anthony P. , Nordsletten, Lars , Wijnen, André J. van , Lewallen, Eric A. , Berglund, Lawrence, Yao, Jie J, van Wijnen, Andre J , Kakar, Sanjeev

Mayo Clinic

The Bone & Joint Journal | September 30, 2019 | Volume: 101-B | Issue: 10 | Pages: 1238-1247

10.1302/0301-620x.101b10.bjj-2018-1282.r2 | PMID 31564153 Get It

Aims Options for the treatment of intra-articular ligament injuries are limited, and insufficient ligament reconstruction can cause painful joint instability, loss of function, and progressive development of degenerative arthritis. This study aimed to assess the capability of a biologically enhanced matrix material for ligament reconstruction to withstand tensile forces within the joint and enhance ligament regeneration needed to regain joint function. Materials and Methods A total of 18 New Zealand rabbits underwent bilateral anterior cruciate ligament reconstruction by autograft, FiberTape, or FiberTape-augmented autograft. Primary outcomes were biomechanical assessment (n = 17), microCT (µCT) assessment (n = 12), histological evaluation (n = 12), and quantitative polymerase chain reaction (qPCR) analysis (n = 6). Results At eight weeks, FiberTape alone or FiberTape-augmented autograft demonstrated increased biomechanical stability compared with autograft regarding ultimate load to failure (p = 0.035), elongation (p = 0.006), and energy absorption (p = 0.022). FiberTape-grafted samples also demonstrated increased bone mineral density in the bone tunnel (p = 0.039). Histological evaluation showed integration of all grafts in the bone tunnels by new bone formation, and limited signs of inflammation overall. A lack of prolonged inflammation in all samples was confirmed by quantification of inflammation biomarkers. However, no regeneration of ligament-like tissue was observed along the suture tape materials. Except for one autograft failure, no adverse events were detected. Conclusion Our results indicate that FiberTape increases the biomechanical performance of intra-articular ligament reconstructions in a verified rabbit model at eight weeks. Within this period, FiberTape did not adversely affect bone tunnel healing or invoke a prolonged elevation in inflammation. Cite this article: Bone Joint J 2019;101-B:1238–1247.
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
Xian, Ying , Li, Zhuokai , Robinson, Jennifer G. , Louie, Michael J. , Koren, Andrew , Goldberg, Anne C. , Roger, Véronique L. , Wilson, Peter W.F. , Wang, Tracy Y., Návar, Ann Marie , Li, Shuang, Virani, Salim S. , Peterson, Eric D.

Mayo Clinic

Journal of the American Heart Association | September 26, 2019 | Volume: 8 | Issue: 19 | Pages: No page available

10.1161/jaha.119.013229 | PMID 31554462 Get It

Background Current treatment guidelines strongly recommend statin therapy for secondary prevention. However, it remains unclear whether patients’ perceptions of cardiovascular risk, beliefs on cholesterol, or the intensity of prescribed statin therapy differs for patients with coronary artery disease ( CAD ) versus cerebrovascular disease (Ce VD ) versus both CAD and Ce VD ( CAD &Ce VD ). Methods and Results The PALM (Patient and Provider Assessment of Lipid Management) registry collected data on statin use, intensity, and core laboratory low‐density lipoprotein cholesterol levels for 3232 secondary prevention patients treated at 133 US clinics. Among individuals with Ce VD only (n=403), CAD only (n=2202), and Ce VD & CAD (n=627), no significant differences were observed in patient‐perceived cardiovascular disease risk, beliefs on cholesterol lowering, or perceived effectiveness and safety of statin therapy. However, patients with Ce VD only were less likely to receive any statin therapy (76.2% versus 86.2%; adjusted odds ratio 0.64, 95% CI 0.45–0.91), or guideline‐recommended statin intensity (34.6% versus 50.4%; adjusted odds ratio 0.60, 95% CI 0.45–0.81) than those with CAD only. Individuals with Ce VD only were also less likely to achieve low‐density lipoprotein cholesterol <100 mg/ dL (59.2% versus 69.7%; adjusted odds ratio 0.79, 95% CI 0.64–0.99) than individuals with CAD alone. There were no significant differences in the use of any statin therapy or guideline‐recommended statin intensity between individuals with CAD &Ce VD and those with CAD only. Conclusions Despite lack of significant differences in patient‐perceived cardiovascular risk or statin beliefs, patients with Ce VD were significantly less likely to receive higher intensity statin or achieve low‐density lipoprotein cholesterol <100 mg/ dL than those with CAD only.
Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus
Laing, Eric D. , Navaratnarajah, Chanakha K. , Silva, Sofia Cheliout Da, Petzing, Stephanie R., Xu, Yan , Sterling, Spencer L. , Wang, Lin‐Fa , Amaya, Moushimi , Nikolov, Dimitar B. , Cattaneo, Roberto , Broder, Christopher C. , Xu, Kai , Wang, Lin-Fa , Cattaneo, Roberto , Broder, Christopher C , Xu, Kai , Xu, Yan, Marsh, Glenn A.

Mayo Clinic

Proceedings of the National Academy of Sciences | September 23, 2019 | Volume: 116 | Issue: 41 | Pages: 20707-20715

10.1073/pnas.1911773116 | PMID 31548390 Get It

Cedar virus (CedV) is a bat-borne henipavirus related to Nipah virus (NiV) and Hendra virus (HeV), zoonotic agents of fatal human disease. CedV receptor-binding protein (G) shares only ∼30% sequence identity with those of NiV and HeV, although they can all use ephrin-B2 as an entry receptor. We demonstrate that CedV also enters cells through additional B- and A-class ephrins (ephrin-B1, ephrin-A2, and ephrin-A5) and report the crystal structure of the CedV G ectodomain alone and in complex with ephrin-B1 or ephrin-B2. The CedV G receptor-binding site is structurally distinct from other henipaviruses, underlying its capability to accommodate additional ephrin receptors. We also show that CedV can enter cells through mouse ephrin-A1 but not human ephrin-A1, which differ by 1 residue in the key contact region. This is evidence of species specific ephrin receptor usage by a henipavirus, and implicates additional ephrin receptors in potential zoonotic transmission.
Surgical Outcomes after Abdominoperineal Resection with Sacrectomy and Soft Tissue Reconstruction: Lessons Learned
Manrique, Oscar J. , Rajesh, Aashish , Bakri, Karim , Tran, Nho V. , Dozois, Eric J. , Rose, Peter S. , Asaad, Malke , Houdek, Matthew T.

Mayo Clinic

Journal of Reconstructive Microsurgery | September 19, 2019 | Volume: 36 | Issue: 01 | Pages: 064-072

10.1055/s-0039-1697629 | PMID 31537019 Get It

Abstract Background Abdominoperineal resection (APR), which involves resection of the rectum, anal canal, and perianal skin, results in a large dead space in the pelvis, devascularized tissues, and high bacterial loads. This predisposes to wound complications, especially in the setting of neoadjuvant chemoradiotherapy. Additional sacral resection further compounds these effects. We aimed to assess perineal wound outcomes and complications in patients who underwent flap reconstruction for APR with sacrectomy (APRS) at our institution. Methods We reviewed the charts of all patients who underwent flap reconstruction for APRS over a 20-year period (1999–2018). Medical comorbidities, details of the surgical procedure, and major and minor wound complications were recorded and analyzed. Results Forty-six patients underwent flap reconstruction following APRS—28 (60%) for colorectal cancer, 8 (17%) for sacral chordoma, and 10 diagnosed with other malignant histologies. Rectus abdominis myocutaneous (RAM) flap reconstruction was used in 42 patients (91%). The median time to the first major perineal complication was 111 days (interquartile range: 22–660 days). Half of our cohort (n = 23) experienced a major perineal complication. No significant differences were found in major or minor perineal or abdominal wall complications between RAM flap and other flaps. APR with high sacrectomy was performed in 27 patients (59%) and was associated with significantly increased full-thickness dehiscence in the perineal region when compared with APR with low sacrectomy, 33 versus 0%, respectively (p = 0.0076). Complete flap loss occurred in one patient. Conclusion The RAM flap was the workhorse flap for pelvic reconstruction following APRS in our cohort. Wound complications are common following APRS. High sacrectomy is associated with higher incidence of complications compared with low sacrectomy. Optimal surgical planning and patient counseling is fundamental to improve current surgical outcomes.
A Next-Generation Single-Port Robotic Surgical System for Transoral Robotic Surgery
Magnuson, J. Scott , Weinstein, Gregory S., Chan, Jason Y. K. , Starmer, Heather M. , Tsang, Raymond K. , Wong, Eddy W. Y. , Rassekh, Christopher H. , Bedi, Nikita , Hong, Steven, O’Malley, Bert W. , Moore, Eric J. , Holsinger, F. Christopher , Wong, Eddy W. Y. , Orosco, Ryan K.

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | September 19, 2019 | Volume: 145 | Issue: 11 | Pages: 1027

10.1001/jamaoto.2019.2654 | PMID 31536129 Get It